In addition to the applicable Total Consideration, tendering holders will receive accrued and unpaid interest to, but not including, the Settlement Date with respect to Notes validly tendered and not validly withdrawn prior to the Consent Payment Deadline.
Each of the tender offers will expire at 12:00 midnight, New York City time, on September 28, 2007, unless any tender offer is extended or earlier terminated at the sole discretion of Mylan (the "Expiration Time"). Holders who validly tender their Notes after the Consent Payment Deadline and on or prior to the Expiration Time will receive the Total Consideration applicable to the Notes so tendered minus the Consent Payment, plus accrued and unpaid interest to, but not including, the Settlement Date.
As of the Consent Payment Deadline, Mylan had received tenders of Notes and deliveries of related consents for approximately $147.4 million in aggregate principal amount of the 2010 Notes, representing 98.26% of the outstanding 2010 Notes, and $349.8 million in aggregate principal amount of the 2015 Notes, representing 99.94% of the outstanding 2015 Notes.
Mylan's obligation to accept, and pay for, Notes of a series validly tendered pursuant to a tender offer is conditioned upon the satisfaction or waiver of various conditions, including consummation of the Transaction and certain general conditions described in the Offer to Purchase.
The complete terms and conditions of the tender offers and consent
solicitations are described in the Offer to Purchase, copies of which may
be obtained by contacting Global Bondholder Services Corporation, the
information agent for the tender offers and consent
|SOURCE Mylan Laboratories Inc.|
Copyright©2007 PR Newswire.
All rights reserved